KAISA HEALTH Posts Wider Interim Loss as Revenue Slips
Stock News
Yesterday
KAISA HEALTH (00876) has announced its financial results for the first half of 2026, revealing a significant increase in losses attributable to equity holders.
The company recorded revenue of approximately HK$285 million for the period, representing a decline of about 15.85% year-on-year. Meanwhile, the loss attributable to equity holders widened to HK$60.168 million, a surge of roughly 6.77 times compared to the same period last year.
Loss per share stood at HK 1.24 cents for the interim period.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.